The combination of novel immune checkpoints HHLA2 and ICOSLG: A new system to predict survival and immune features in esophageal squamous cell carcinoma

Studies on immune checkpoint inhibitors targeting B7-CD28 family pathways in esophageal squamous cell carcinoma (ESCC) have shown promising results. However, a comprehensive understanding of B7-CD28 family members in ESCC is still limited. This study aimed to construct a novel B7-CD28 family-based p...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chaoqi, Wang, Feng, Sun, Nan, Zhang, Zhen, Zhang, Guochao, Zhang, Zhihui, Luo, Yuejun, Che, Yun, Cheng, Hong, Li, Jiagen, He, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chongqing Medical University 2020
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843897/
https://www.ncbi.nlm.nih.gov/pubmed/35224157
http://dx.doi.org/10.1016/j.gendis.2020.08.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843897/
https://www.ncbi.nlm.nih.gov/pubmed/35224157
http://dx.doi.org/10.1016/j.gendis.2020.08.003

Ejemplares similares